Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma's Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine Psychedelics Investing
Seelos Therapeutics Raises $20 Million in Private Placement of Senior Secured Convertible Note Psychedelics Investing
Hollister Biosciences Inc. Announces Results of Its 2021 Annual General and Special Shareholder Meeting Psychedelics Investing
Love Pharma Signs Letter of Intent to Acquire 100% Interest in MicrDoz Therapy Inc. To Expedite Pilot Study of Psilocybin Assisted Treatment of Cannabis Use Disorder with World Leading University Pharmaceutical Investing
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001 Psychedelics Investing
Numinus to Host Q4 and 2021 Annual Results Conference Call on December 9, 2021 Pharmaceutical Investing
Goodness Growth Holdings Announces Closing of Purchase of Charm City Medicus Dispensary in Baltimore, Maryland Psychedelics Investing
Goodness Growth Holdings Closes Previously Announced Divestiture of Arizona Dispensary License Psychedelics Investing
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
